Aimee Kristine Armstrong, MD

• Chief, Pediatric Cardiology and Congenital Interventional Cardiology
• Co-Director, Blalock-Taussig-Thomas Pediatric & Congenital Heart Center

Aimee Armstrong is director of pediatric cardiology and congenital interventional cardiology and co-director of the Blalock-Taussig-Thomas Pediatric and Congenital Heart Center. She also holds the Helen B. Taussig Chair in Pediatric Cardiology.

Dr. Armstrong received her medical degree from Northwestern University Medical School in 1997 and completed pediatric residency at Riley Hospital for Children in Indianapolis in 2000. She then completed her fellowship in pediatric cardiology in 2003 followed by training in pediatric interventional cardiac catheterization and pediatric cardiac critical care in 2004, both at C.S. Mott Children’s Hospital at the University of Michigan. She was on faculty as a congenital interventional cardiologist at University of Michigan for 11 years before being recruited to The Ohio State University to serve as director of cardiac catheterization and interventional therapies, as well as director of the Interventional Cardiology Fellowship Program at Nationwide Children’s Hospital. 

Meet Pediatric Interventional Cardiologist Aimee Armstrong, M.D.

Cardiac device development and preclinical and clinical trials, Fetal cardiac intervention preclinical and clinical research, MRI-guided interventional cardiac catheterization

Over the past 20 years, Dr. Armstrong has led the formation of fetal cardiac intervention teams, working with maternal-fetal medicine, fetal cardiology and anesthesia, at both the University of Michigan and Nationwide Children’s Hospital/UH Rainbow Babies and Children’s Hospital. In collaboration with biomedical and tissue engineers, she performed innovative translational work in this field, creating and implanting the first completely bioresorbable fetal heart valve in a large animal fetal model. Dr. Armstrong is a leader in 3D imaging for congenital interventional catheterization, as well as the developing field of interventional cardiac MRI (ICMR), for which she is active in translational research. Currently, she is performing preclinical work in the use of low-field (0.55T) MR for real-time imaging during congenital intervention.

Dr. Armstrong also has a passion for interventional device development and outcomes research. Since 2010, she has been the site principal investigator for many device IDE and post-approval studies. She has significantly contributed to the understanding of outcomes after self-expanding transcatheter pulmonary valves (TPVs), as she created and manages the only registry that includes different types of self-expanding TPVs. Furthermore, she is working with the Heart & Valve Collaboratory and the FDA on writing an Academic Research Consortium (ARC) manuscript to define adverse events for surgical and transcatheter pulmonary valve trials. Dr. Armstrong is the national principal investigator for the Starlight Lifeline Ductus Arteriosus IDE 10-center study. Her preclinical and translational research encompasses the area of device development as well, as she has completed preclinical studies on the Starlight Cardiovascular Pulmonary Flow Restrictor.

• Young Investigator Award for Clinical Research/Health Services Research, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, 2003
• Top Resident Teachers, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, 2006–2007
• Top Teachers of Housestaff and Medical Students, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, 2010
• Best Pediatric Paper of Catheterization and Cardiovascular Interventions 2019, SCAI 2020 presentation, 2020
• Founding Fellow, The PICS Society, 2021
• Pediatric Interventional Cardiology Early Career Society (PICES) Mentorship Award – Presented to a senior interventional cardiologist who has helped develop and support PICES members, 2021
• PICS Symposium 2022 Best Moderated Poster Abstract, 2022
• PICS Symposium 2022 Finalist for the Charles S. Kleinman Scientific Scholarship Award, 2022

• Mentor, Society for Cardiovascular Angiography and Interventions Pediatric Interventional Cardiology Early Career Society (PICES) Mentorship Program, 2016–2018
• Founding Chair, Early Career Development Committee, The PICS Society, 2020-2024
• Co-founder and co-director, The PICS Early Career Development Academy – a two-year program to advance the careers of early career interventionalists throughout the world through mentoring, didactics, simulations, teamwork and research, 2024-2025
• Member, American College of Cardiology Reducing Radiation Risk (RRR) Quality Improvement Advisory Committee, 2013-2014
• Co-director, American College of Cardiology IMPACT Registry Reducing Radiation Risk (RRR) Quality Improvement Program, 2014-2018
• Co-chair, Congenital Cardiac Catheterization Project on Outcomes (C3PO) Risk Mitigation Working Group, 2020-present
• Member, Congenital Cardiac Catheterization Outcomes Project (C3PO) Steering Committee, 2022-present
• Member, International Fetal Cardiac Intervention Registry Steering Committee, 2016-present
• Intersocietal Accreditation Commission (IAC) Cardiovascular Catheterization Board of Directors, 2017-present
• President-Elect, Intersocietal Accreditation Commission (IAC) Cardiovascular Catheterization Board of Directors, 2017-2019
• President, Intersocietal Accreditation Commission (IAC) Cardiovascular Catheterization Board of Directors, 2020-2021
• Member, Steering Committee for the Association for European Paediatric and Congenital Cardiology (AEPC) study on the Effect of Fetal Aortic Valvuloplasty on Outcomes: a prospective observational cohort study with a comparison cohort, 2020-0resent
• Member, Heart Valve Collaboratory, Pediatric (Bambino) Heart Valve Working Group, 2023
• Co-chair, Heart Valve Collaboratory, Pediatric Clinical Working Group, 2024-present
• Co-chair, Congenital Pulmonary Valve Academic Research Consortium Writing Group, 2024-present
• Member, Society of Cardiovascular Angiography and Interventions (SCAI) Education Committee, 2022-2025
• Member, Society of Cardiovascular Angiography and Interventions (SCAI) Communications Committee, 2022-2025
• Pediatric and Congenital Interventional Cardiovascular (PICS) Society Founding Fellow, 2021-present
• Board Member, PICS Society Board of Directors, 2023-2026
• Member, PICS Society Health Policy and Regulatory Affairs Committee, 2024-present
• Society of Cardiovascular Angiography & Interventions (SCAI) Congenital Heart Disease (CHD) Program Committee, 2020-3023
  • 05/2020-05/2021 CHD Assistant Chair for SCAI 2021, Virtual
  • 05/2021-05/2022 CHD Associate Chair for SCAI 2022, Atlanta, GA
  • 05/2022-05/2023 CHD Program Chair for SCAI 2023, Phoenix, AZ
• Co-director, PICS Symposium, 2020-2025
• Director, PICS Symposium, 2025-present
• Co-director, Heart & Valve Collaboratory Workshop: Vanishing Tools: A National Call to Safeguard Congenital Heart Care, co-sponsored by H&VC, Mussallem CHD Alliance, PICS Society, and SCAI, 2026